These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22970210)

  • 1. Genomic DNA copy-number alterations of the let-7 family in human cancers.
    Wang Y; Hu X; Greshock J; Shen L; Yang X; Shao Z; Liang S; Tanyi JL; Sood AK; Zhang L
    PLoS One; 2012; 7(9):e44399. PubMed ID: 22970210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
    Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
    Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.
    Bayani J; Kuzmanov U; Saraon P; Fung WA; Soosaipillai A; Squire JA; Diamandis EP
    Clin Chem; 2013 Jan; 59(1):296-305. PubMed ID: 23136250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRB inhibited cell proliferation through let-7b-E2F1 in breast cancer.
    Asavasupreechar T; Saito-Koyama R; Miki Y; Tamai K; Abe J; Inoue C; Sato I; Boonyaratanakornkit V; Sasano H
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37130271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.
    Agostini A; Brunetti M; Davidson B; Tropé CG; Heim S; Panagopoulos I; Micci F
    Oncotarget; 2017 Mar; 8(13):21554-21560. PubMed ID: 28423547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNAs exhibit high frequency genomic alterations in human cancer.
    Zhang L; Huang J; Yang N; Greshock J; Megraw MS; Giannakakis A; Liang S; Naylor TL; Barchetti A; Ward MR; Yao G; Medina A; O'brien-Jenkins A; Katsaros D; Hatzigeorgiou A; Gimotty PA; Weber BL; Coukos G
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9136-41. PubMed ID: 16754881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Analysis and in Vitro Validation of Let-7b and Let-7c in Breast Cancer.
    Bozgeyik E
    Comput Biol Chem; 2020 Feb; 84():107191. PubMed ID: 31901542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.
    Miao JT; Gao JH; Chen YQ; Chen H; Meng HY; Lou G
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors.
    Wielgos ME; Rajbhandari R; Cooper TS; Wei S; Nozell S; Yang ES
    Mol Cancer Res; 2017 Mar; 15(3):340-347. PubMed ID: 28031413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic comparison of copy number alterations in four types of female cancer.
    Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
    BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors.
    Aure MR; Leivonen SK; Fleischer T; Zhu Q; Overgaard J; Alsner J; Tramm T; Louhimo R; Alnæs GI; Perälä M; Busato F; Touleimat N; Tost J; Børresen-Dale AL; Hautaniemi S; Troyanskaya OG; Lingjærde OC; Sahlberg KK; Kristensen VN
    Genome Biol; 2013 Nov; 14(11):R126. PubMed ID: 24257477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
    Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG
    Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b.
    Gao Y; Meng H; Liu S; Hu J; Zhang Y; Jiao T; Liu Y; Ou J; Wang D; Yao L; Liu S; Hui N
    Hum Mol Genet; 2015 Feb; 24(3):841-52. PubMed ID: 25292198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
    García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Meneses García A; Hernández De La Cruz ON; Astudillo-De La Vega H; Isla-Ortiz D; Marchat LA; Salinas-Vera YM; Carlos-Reyes Á; López-González S; Ramos-Payan R; López-Camarillo C
    Oncol Rep; 2018 Jun; 39(6):3086-3094. PubMed ID: 29658612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of let-7b-5p inhibits ovarian cancer cell proliferation and stemness characteristics by Asp-Glu-Ala-Asp-box helicase 19A.
    Huang X; Dong H; Liu Y; Yu F; Yang S; Chen Z; Li J
    Bioengineered; 2021 Dec; 12(1):7666-7677. PubMed ID: 34612147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
    Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
    Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.
    Xiao M; Guo J; Xie L; Yang C; Gong L; Wang Z; Cai J
    Mol Cancer Res; 2020 Mar; 18(3):436-447. PubMed ID: 31722968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
    Helland Å; Anglesio MS; George J; Cowin PA; Johnstone CN; House CM; Sheppard KE; Etemadmoghadam D; Melnyk N; Rustgi AK; Phillips WA; Johnsen H; Holm R; Kristensen GB; Birrer MJ; ; Pearson RB; Børresen-Dale AL; Huntsman DG; deFazio A; Creighton CJ; Smyth GK; Bowtell DD
    PLoS One; 2011 Apr; 6(4):e18064. PubMed ID: 21533284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of BSG expression.
    Ma L; Li GZ; Wu ZS; Meng G
    Med Oncol; 2014 Jan; 31(1):773. PubMed ID: 24264599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.